/Lists

Biotech Series A Investors & VC Firms

1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.

Sofinnova Partners
ParisSeed–Late Stage$540K – $27M
79 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
35 people
BDC Venture Capital
MontrealPre-Seed–Growth$365K – $25.6M
109 people
Andera Partners
ParisSeed–Growth
44 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Oak HC/FT
StamfordSeed–Growth
59 people
Abstract Ventures
San FranciscoPre-Seed–Series C$250K – $750K
6 people
JAFCO Group
TokyoPre-Seed–Growth
89 people
Pear VC
San FranciscoPre-Seed–Series A$150K – $4M
29 people
Gobi Partners
Hong KongSeed–Series A
73 people
Maryland TEDCO
ColumbiaPre-Seed–Series A$500K – $1.5M
75 people
ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Korea Investment Partners
SeoulSeed–Series C$3M – $10M
80 people
NFX
San FranciscoPre-Seed–Series A$250K – $5M
23 people
Correlation Ventures
San FranciscoPre-Seed–Series A$100K – $4M
19 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
60 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people
CDP Venture Capital
RomaPre-Seed–Growth
44 people
Rockstart
AmsterdamPre-Seed–Series B$114.4K – $2.3M
26 people
Future Planet Capital
LondonSeed–Growth
36 people
Mana Ventures
EsteroSeed–Series A
8 people
Amplify Partners
Menlo ParkPre-Seed–Series A$500K – $5M
31 people
Paladin Capital Group
WashingtonSeed–Growth$100K – $5M
65 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.